期刊文献+

肝细胞生长因子、碱性成纤维细胞生长因子及血管源性生长因子在成人烟雾病不同阶段的变化 被引量:3

Changes of HGF, FGF and VEGF in different pathological stages of adult moyamoya disease
下载PDF
导出
摘要 目的 探讨成人烟雾病不同阶段中肝细胞生长因子(HGF)、碱性成纤维细胞生长因子(b-FGF)及血管源性生长因子(VEGF)的变化。方法 回顾性分析2013年11月~2014年12月江西省人民医院(以下简称“我院”)神经内科住院的行全脑血管造影检查确诊为烟雾病的41例患者临床资料,根据Suzuki分期,8例患者为早期(Suzuki分期1~2期),17例为中期(Suzuki分期3~4期),16例为晚期(Suzuki分期5~6期),同时选择在我院诊治的40例脑动脉粥样硬化患者为阳性对照,另选择我院20例健康体检者为正常对照。采用酶联免疫吸附法(ELISA法)检测上述人群血清中HGF、b-FGF及VEGF浓度。结果 烟雾病早、中、晚期患者的HGF与动脉粥样硬化患者、健康人比较,差异有统计学意义(P〈0.05)。烟雾病晚期患者b-FGF与动脉粥样硬化患者、健康人比较,差异有统计学意义(P〈0.05)烟雾病早期患者VEGF与动脉粥样硬化患者、健康人比较,差异有统计学意义(P〈0.05)。结论 烟雾病的发生发展过程HGF、b-FGF及VEGF均有参与,但三者作用并不相同,HGF可能在烟雾病整个发生发展过程中均发挥作用,而b-FGF可能在烟雾病晚期发生发展中发挥了作用,VEGF则可能在烟雾病早期发生发展中发挥了作用。 Objective To investigate the changes of hepatocyte growth factor (HGF), basic fibroblast growth factor (b- FGF) and blood vessels origin of growth factor (VEGF) in the different pathological stages of adult moyamoya disease (MMD). Methods The clinical data of 51 patients with MMD were retrospectively analyzed from November 2013 to December 2014 in the People's Hospital of Jiangxi Province, all patients received examinations of Digital Subtraction Angiography, according to Suzuki diagnostic criteria, 8 patients were early stage (Suzuki 1-2 stage), 17 cases were middle stage (Suzuki 3-5 stage), 16 cases were late stage (Suzuki 5-6 stage). At same time, 40 patients with cerebral atherosclerosis were selected as positive control, and 20 normal people were selected as normal control. HGF, b-FGF and VEGF concentration in serum measured by using enzyme-linked immunosorbent (ELISA). Results HGF in the early, middle and late stage of MMD patients were compared to atherosclerosis patients and healthy persons, the differences were statistically significant (P 〈 0.05). b-FGF in the late stage of MMD were compared with atherosclerosis patients and healthy persons, the differences were statistically significant (P 〈 0.05). VEGF in the early stage of MMD were com- pared with atherosclerosis patients and healthy persons, the differences were statistically significant (P 〈 0.05). Conclusion HGF, b-FGF and VEGF are involved in the development process of MMD, HGF may play a role in the whole development process in MMD, b-FGF may play a role at the late MMD developing, and VEGF may play a role in early development in MMD.
出处 《中国医药导报》 CAS 2016年第16期46-49,共4页 China Medical Herald
基金 江西省卫生厅科技计划(20141016)
关键词 烟雾病 肝细胞生长因子 碱性成纤维细胞生长因子 血管源性生长因子 Moyamoya disease Hepatocyte growth factor Basic fibroblast growth factor Blood vessels origin of growth factor
  • 相关文献

参考文献20

  • 1Bang OY, Goyal M, Liebeskind DS. Collateral Circulationin Ischemic Stroke: Assessment Tools and TherapeuticStrategies [J]. Stroke,2015,46( 11): 3302-3309.
  • 2Cuccione E,Padovano G,Versace A,et al. Cerebral col-lateral circulation in experimental ischemic stroke [J]. ExpTransl Stroke Med,2016,8:2.
  • 3Baltsavias G,Khan N,Valavanis A. The collateral circula-tion in pediatric moyamoya disease [J]. Childs Nerv Syst,2015,31(3):389-398.
  • 4Suzuki J,Takaku A. Cerebrovascular “moyamoya” disease.Disease showing abnormal net -like vessels in base ofbrain [J]. Arch Neurol, 1969,20 : 288-299.
  • 5刘文华,倪冠中,黄显军,孙文,朱武生,徐格林,刘新峰.成年型烟雾病侧支循环的分布模式[J].中华神经科杂志,2012,45(3):149-153. 被引量:21
  • 6Nanba R, Kuroda S, Ishikawa T,et al. Increased expres-sion of hepatocyte growth factor in cerebrospinal fluid andintracranial artery in moyamoya disease [J]. Stroke, 2004,35(12):2837-42.
  • 7Suzui H,Hoshimaru M,Takahashi JA,et al. Immunohisto-chemical reactions for fibroblast growth factor receptor inarteries of patients with moyamoya disease [J]. Neurosurgery,1994,35(l):20-24.
  • 8Park YS,Young JJ,Kim HS,et al. The role of VEGF andKDR Polymorphisms in Moyamoya disease and collateralrevascularization [J]. PLoS One,201,7(10) :e47158.
  • 9Sakamoto S, Kiura Y, Yamasaki F,et al. Expression ofvascular endothelial growth factor in dura mater of pa-tients withmoyamoya disease [J]. Neurosurg Rev, 2008,31:77-81.
  • 10程道宾,张皆德,吕芳,秦超,韦维.烟雾病的遗传学和病理生理学机制[J].国际脑血管病杂志,2014,22(6):458-463. 被引量:13

二级参考文献14

  • 1Suzuki J, Takaku A. Cerebrovascular " moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol, 1969, 20: 288-299.
  • 2Kuroda S, Ishikawa T, Houkin K, et al. Incidence and clinical features of disease progression in adult moyamoya disease. Stroke, 2005, 36: 2148-2153.
  • 3Liu W, Zhu S, Wang X, et al. Evaluation of angiographic changes of the anterior choroidal and posterior communicating arteries for predicting cerebrovaseular lesions in adult moyamoya disease. J Clin Neurosei, 2011, 18:374-378.
  • 4Liu X, Xu G, Wu W, et al. Subtypes and one-year survival of first-ever stroke in Chinese patients: The Nanjing Stroke Registry. Cerebrovasc Dis, 2006, 22 : 130-136.
  • 5Liebeskind DS. Collaterals in acute stroke: beyond the clot. Neuroimaging Clin N Am, 2005, 15:553-573.
  • 6Liu W, Xu G, Yue X, et al. Hyperintense vessels on FLAIR: a useful non-invasive method for assessing intracerebral .collaterals. Eur J Radiol, 2011, 80:786-791.
  • 7Liebeskind DS. Collateral circulation. Stroke, 2003, 34 : 2279- 2284.
  • 8Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med, 2009, 360:1226-1237.
  • 9Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol, 2008, 7:1056-1066.
  • 10陈孝东,曹勇军.烟雾病研究进展[J].国际脑血管病杂志,2009,17(9):700-704. 被引量:15

共引文献32

同被引文献33

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部